cro.directory
← Compare landing

Axcelead Drug Discovery Partners, Inc. vs Explicyte

Side-by-side profile data from each company listing. Missing fields stay blank rather than filled with assumptions.

CategoryAxcelead Drug Discovery Partners, Inc.Explicyte
SummaryAxcelead provides integrated drug discovery research services to pharmaceutical companies, biotech ventures, and academic institutions. Founded in 2017 from Takeda's drug discovery research base, the company offers expertise across small molecules, nucleic acids, antibodies, and multiple therapeutic modalities.Oncology CRO offering FFPE target discovery, 2D/3D immuno-oncology efficacy and mechanism-of-action assays, and ISO-certified IHC/IF trial biomarker services. Serves biotech and pharma sponsors.
Services
  • Discovery Research
  • Target Identification & Validation
  • High-Throughput Screening
  • Medicinal Chemistry
  • Computational & In-Silico Drug Discovery
  • Preclinical In Vitro Studies
  • In Vitro Pharmacology
  • In Vitro ADME / DMPK
  • Safety Pharmacology
  • Genetic Toxicology
  • Preclinical In Vivo Studies
  • In Vivo Efficacy Models
  • In Vivo PK / PD Studies
  • GLP Toxicology
  • Specialized & Large-Animal Models
  • Bioanalysis
  • Biomarker Assays
  • Flow Cytometry Services
  • Translational Research
  • Immunology & Inflammation Services
  • Oncology Specialty Services
  • CNS Specialty Services
  • Cardiovascular & Metabolic Specialty Services
  • Pathology & Histology Services
  • Genomics & Sequencing Services
  • Proteomics Services
  • Bioinformatics & Data Science
  • Discovery Research
  • Target Identification & Validation
  • Preclinical In Vitro Studies
  • In Vitro Pharmacology
  • Biomarker Assays
  • Flow Cytometry Services
  • Translational Research
  • Immunology & Inflammation Services
  • Oncology Specialty Services
  • Pathology & Histology Services
  • Genomics & Sequencing Services
  • Proteomics Services
  • Bioinformatics & Data Science
Modalities
  • Small Molecule
  • Biologics (Monoclonal Antibodies)
  • Antibody-Drug Conjugate (ADC)
  • Oligonucleotide
  • mRNA
  • Peptide
  • Biologics (Other)
  • Antibody-Drug Conjugate (ADC)
Indications
  • Oncology
  • Immunology
  • Neurology
  • Metabolic
  • Cardiovascular
  • Nephrology
  • Oncology
Phases
  • Discovery
  • Preclinical (General)
  • Preclinical (IND-Enabling)
  • Discovery
  • Preclinical (General)
  • Preclinical (IND-Enabling)
Sourcing models
  • Full-Service Outsourcing (FSO)
Data not yet provided.
LocationsData not yet provided.
  • Bordeaux, Bordeaux, France
CertificationsData not yet provided.
  • ISO · Identifier: ISO 9001
  • ISO · Identifier: ISO 13485
  • 10x Genomics · Identifier: 10x Genomics Certified Service Provider

Find similar companies

Axcelead Drug Discovery Partners, Inc. alternatives · Explicyte alternatives

Markdown mirror: /compare/axcelead/explicyte.md